Multiple sclerosis and COVID-19: Assessing risk perception, patient behaviors and access to disease-modifying therapies
暂无分享,去创建一个
E. Tallantyre | M. Wardle | N. Robertson | R. Wynford-Thomas | R. Beesley | S. Loveless | V. Anderson | M. Willis | M. Cauchi | L. Davies | M. Upcott | E. Norton | T. Pickersgill | E. Uzochukwu